Bharat rashtra samithi articles

  • Bharat Biotech founder is new IVMA president

    Hyderabad: Bharat Biotech founder chairman Dr Krishna Ella has taken over as the president of the Indian Vaccine Manufacturers Association (IVMA) for a two year period from April 2024-2026. Dr Ella takes over as IVMA president from Serum Institute of India (SII) CEO Adar Poonawala, who was helming the body from 2019 to March 2024.For the two year term, Biological E Ltd managing director Mahima Datla will be the vice president of the vaccine manufacturers’ body, while Bharat Biotech CFO T...
  • Bharat Biotech stresses on Covaxin’s safety record

    Hyderabad: Days after AstraZeneca’s admision in a UK court on its Covid-19 vaccine causing a rare side-effect — Thrombosis with Thrombocytopenia Syndrome (TTS), Indian vaccine maker Bharat Biotech on Thursday issued a statement stressing on the safety of its indigenous vaccine Covaxin to allay public concerns over Covid vaccines.AstraZeneca’s vaccine was manufactured under the Covishield brandname in India by Pune-based Serum Institute of India. Hyderabad-based Bharat Biotech developed the...
  • 'Safety first', says Bharat Biotech amid AstraZeneca row

    NEW DELHI: Bharat Biotech on Thursday assured Covaxin's safety amid debate over Astrazeneca's admission that its Covid-19 vaccine, sold as Covishield in India, could cause "rare' side effects.The vaccine company posted a statement on X, mentioning that Covaxin was the sole Covid-19 vaccine in the government's Covid-19 immunisation programme to have conducted efficacy trials in India.The vaccine manufacturer mentioned that Covaxin was created with a primary focus on safety before considering...